Therapeutic modulation of PTPs is therefore evaluated in the context of autoimmune disorders and in tumor immunotherapy [48] but remains challenging in part due to the diverse functions of PTPs in dephosphorylating not only JAKs and their receptors but also a multitude of other intracellular signaling nodes. The gene discussed is PTS; the disease is autoimmune disease.